AdCare Health Systems, Inc. | ||||
PRICING TERM SHEET | ||||
10.875% Series A Cumulative Redeemable Preferred Stock | ||||
(Liquidation Preference $25.00 Per Share) | ||||
May 28, 2015 |
Issuer: | AdCare Health Systems, Inc. |
Security: | 10.875% Series A Cumulative Redeemable Preferred Stock (the “Series A Preferred Stock”) |
Number of Shares Offered: | 588,235 shares |
Joint Book-Running Managers: | MLV & Co. LLC and Northland Capital Markets. Northland Capital Markets is the trade name for certain capital markets and investment banking activities of Northland Securities, Inc., member FINRA/SIPC. |
Co-Managers: | GVC Capital LLC and National Securities Corporation |
Best Efforts: | The underwriters are selling the shares of Series A Preferred Stock on a “best efforts” basis and are not required to purchase any shares of the Series A Preferred Stock for their own account, but will use their best efforts to sell the securities offered by the Preliminary Prospectus Supplement and the accompanying prospectus. |
Ticker/Exchange: | “ADK.PRA”/NYSE MKT |
Public Offering Price: | $25.50 per share |
Underwriting Discount and Commissions: | $787,500 |
Net Proceeds to the Company, before expenses: | $14,212,493 |
Liquidation Preference: | $25.00 per share |
Dividend Rate: | 10.875% of the $25.00 liquidation preference per share per annum (equivalent to $2.7187 per share per annum) |
Penalty Dividend Rate: | 12.875% of the $25.00 liquidation preference per share per annum (equivalent to $3.2187 per share per annum) |
Dividend Payment Dates: | On or about the last calendar day of each of March, June, September and December. |
Trade Date: | May 28, 2015 |
Expected Settlement Date: | June 2, 2015 (T + 3) |
Optional Redemption: | We may not redeem the Series A Preferred Stock prior to December 1, 2017, except we are required to redeem the Series A Preferred Stock following a Change of Control (as defined in the Preliminary Prospectus Supplement). On and after December 1, 2017, we may redeem the Series A Preferred Stock for cash at our option, from time to time, in whole or in part, at a redemption rate of $25.00 per share, plus accrued and unpaid dividends (whether or not earned or declared) to the redemption date. See “Description of the Series A Preferred Stock-Redemption-General” in the Preliminary Prospectus Supplement. |
Special Redemption Upon Change of Control: | Following a Change of Control of us by a person or entity, we (or the acquiring entity) will be required to redeem the Series A Preferred Stock, in whole but not in part, within 120 days after the date on which the Change of Control has occurred for cash, at the price of $25.00 per share, plus accrued and unpaid dividends (whether or not earned or declared) to the redemption date. See “Description of the Series A Preferred Stock-Redemption-Special Redemption Upon Change of Control” in the Preliminary Prospectus Supplement. |
Maturity: | The Series A Preferred Stock has no stated maturity and will not be subject to any sinking fund or mandatory redemption, except following a Change of Control. Accordingly, absent a Change of Control, the shares of Series A Preferred Stock will remain outstanding indefinitely unless we decide to redeem them. |
CUSIP/ISIN: | 00650W 409 / US00650W4096 |